account_balance
Investment manager · 13F filer · SEC CIK 1617201
Prosight Management, LP
Reported value$580Mas of Jun 30, 2026
Positions36 5 new, 15 sold out
Top 10 weight71%LKFT alone is 11%
FiledAug 1445 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
LKFT
Lakefront Biotherapeutics NV
10.6%Added
JANX
Janux Therapeutics INC
10.1%Added
NKTR
Nektar Therapeutics
9.7%Added
BSX
Boston Scientific Corp
9.3%Added
STTK
Shattuck Labs INC
7.1%Added
INSM
Insmed INC
6.9%New
ALNY
Alnylam Pharmaceuticals INC
5.1%Added
SNDX
Syndax Pharmaceuticals INC
4.5%Added
KURA
Kura Oncology INC
3.8%Trimmed
ALKS
Alkermes PLC
3.6%Trimmed
26 others
29.3%
Box size is the share of the fund's reported holdings. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
What changed